Phenna Group has acquired CEIMIC, a prominent life sciences testing company in Brazil, marking its first expansion into the Latin American market.

Information on the Target

Phenna Group, headquartered in Nottingham, UK, specializes in investing in niche, independent Testing, Inspection, Certification, and Compliance (TICC) companies across a variety of sectors. Its mission is to enhance customer confidence by providing exceptional testing and assurance services. The acquisition of CEIMIC is the 14th transaction initiated by Phenna Group in 2023, marking a significant expansion into the Latin American region and enhancing its rapidly growing platform in the food and life sciences sectors.

Established in 2017 and based in Sao Paulo, Brazil, CEIMIC is an expert provider of life sciences testing services, employing over 300 specialists. The company has experienced continuous growth and now boasts one of the most extensive laboratory networks in the Americas, delivering quality analytical services, sampling, technology, and logistics across seven Latin American countries, along with the Dominican Republic and the USA. CEIMIC's comprehensive service offerings cover environmental testing, air quality, and food and pharmaceutical markets, emphasizing the sanitary control and quality assurance of food at all stages to ensure consumer safety.

Industry Overview in Brazil

Brazil's life sciences and testing industry has seen robust growth driven by increasing regulatory requirements and heightened awareness of food safety and environmental standards. The country's vast agricultural landscape necessitates stringent testing and c